Pulmonary Alveolar Proteinosis
📧 Sign up to get email alerts when something new happens for Pulmonary Alveolar Proteinosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Rituximab for Anti-cytokine Autoantibody-Associated Diseases [Phase 1]
Phase 1 trial evaluating Rituximab for anti-cytokine autoantibody-associated diseases, including Pulmonary Alveolar Proteinosis and Severe M…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Macrophages, GM-CSF and MARS Proteinosis
Clinical trial update from Assistance Publique - Hôpitaux de Paris describes macrophage-based approaches and GM-CSF therapy for Pulmonary Al…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A National Registry For Pulmonary Alveolar Proteinosis
This clinical trial registry entry describes a national registry for Pulmonary Alveolar Proteinosis, sponsored by Cincinnati Children's Hosp…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating methionine in patients with pulmonary alveolar proteinosis caused by MARS gene mutations has completed…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke
A clinical trial protocol to establish a system for early warning and prognostic evaluation in heat stroke patients; the study is not yet re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis [Phase 2]
This clinical trial update describes a Phase 2 study investigating local delivery of GM-CSF via bronchoscopy to treat autoimmune pulmonary a…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis [Phase 2]
A Phase 2 prospective trial evaluated rituximab for primary pulmonary alveolar proteinosis; study status is completed.
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan [Phase 2]
A Phase 2 efficacy trial of inhaled GM-CSF for autoimmune pulmonary alveolar proteinosis in Japan has completed.
-
CLINICAL_TRIALS research · 2018-07-10Clinical Trial Update: A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients
This document reports an update on a study investigating circulating exosome proteomics in patients with gallbladder cancer.
-
CLINICAL_TRIALS research · 2017-10-20Clinical Trial Update: Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis [Phase 2]
This clinical trial update describes a Phase 2 study of sequential whole lung lavage followed by inhaled GM-CSF for autoimmune pulmonary alv…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects [Phase 1]
Phase 1 trial of inhaled molgramostim (rhGM-CSF) in healthy adults has completed, evaluating safety and tolerability for potential pulmonary…
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial
The multicenter international cross-sectional evaluation study on Pulmonary alveolar proteinosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: GM-CSF in Patients With Pulmonary Alveolar Proteinosis [Phase 2]
A Phase 2 clinical trial evaluating GM-CSF in patients with Pulmonary Alveolar Proteinosis was terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP. [Phase 2]
This document provides a Phase 2 trial update on subcutaneous low-dose recombinant human GM-CSF, used with or without whole lung lavage, for…